Phase 1 Bone Sarcoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Resectable SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Bone Sarcoma+2 more

Roswell Park Cancer Institute99 enrolled1 locationNCT03965234

Recruiting

Phase 1

In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

Soft Tissue SarcomaBone SarcomaPulmonary Metastases

University Health Network, Toronto17 enrolled1 locationNCT02811523

Recruiting

Phase 1

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Soft Tissue SarcomaBone Sarcoma

M.D. Anderson Cancer Center40 enrolled1 locationNCT05621668